Pancreatic Neoplasms: all 3,310 studies
Page 3 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid TumorsRecruitingNCT07300150Phase 1
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)RecruitingNCT07284277Phase 1/2
- A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruitingNCT07277413Phase 1
- Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related DiabetesNot yet recruitingNCT07272109Phase 3
- A Study of Multiparametric Ultrasound Imaging MethodsRecruitingNCT07270237Not applicable
- PULSAR in Systemic Therapy for Pancreatic CancerRecruitingNCT07269626Phase 2
- Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic CancerRecruitingNCT07262567Phase 3
- Association Between Composition of the Gut Microbiota and Nutritional Status in Digestive OncologyNot yet recruitingNCT07260617
- Carbon Ion Radiotherapy in Frail Patients With Pancreatic CancerRecruitingNCT07257523Phase 2
- A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic CancerRecruitingNCT07255404Phase 2
- Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic CancerRecruitingNCT07254091Early Phase 1
- Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)RecruitingNCT07252232Phase 3
- The Role of Microbiota in Pancreatic Cancer and Precursor LesionsRecruitingNCT07250100
- A First-in-Human Study of FID-022 in Solid Tumor PatientsRecruitingNCT07249775
- A Study of DEG6498 in Participants With Solid TumorsRecruitingNCT07244835Phase 1
- Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)RecruitingNCT07243262
- Study on Efficacy and Safety of VMAT Technique With Local Dose Escalation for Unresectable Pancreatic CancerNot yet recruitingNCT07242911
- Surgery for Locally Unresectable Pancreatic CancerRecruitingNCT07241663
- B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.RecruitingNCT07236177Early Phase 1
- Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head CancerRecruitingNCT07232810Not applicable
- Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylateRecruitingNCT07230509Phase 2
- Clinical Study of 177Lu-CTR-FAPI In the Treatment of Patients With Advanced, Metastatic Solid TumorsRecruitingNCT07229768Early Phase 1
- A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07229313Phase 1
- BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic AdenocarcinomaRecruitingNCT07226856Phase 2
- A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid MalignanciesRecruitingNCT07223047Phase 1/2
- Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)RecruitingNCT07219238Phase 2/3
- Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT07214298Phase 1/2
- AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.Not yet recruitingNCT07208539Phase 2
- In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary CancersRecruitingNCT07206355
- TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic AdenocarcinomaRecruitingNCT07189195Phase 1
- EXoPERT EMERALD Clinical StudyRecruitingNCT07186296
- CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid TumorsRecruitingNCT07179692Phase 1
- Expectation, Pain Outcomes, and Pain Medication Following Oncology Abdominal Surgery: A Cohort StudyNot yet recruitingNCT07176052
- JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment FailureNot yet recruitingNCT07175389Phase 1/2
- Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic CancerRecruitingNCT07173387Phase 2
- PROMs After PancreatectomyRecruitingNCT07173257
- A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT07172802Phase 1/2
- Clinical Application of PET Imaging Targeting GPA33 in Malignant TumorsNot yet recruitingNCT07172503Not applicable
- Development & Clinical Application of K-PaC Registry Version 2.0Enrolling by invitationNCT07171515
- PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.RecruitingNCT07167264Not applicable
- The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic CancerNot yet recruitingNCT07160283Phase 2
- A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.RecruitingNCT07157033Phase 1/2
- NON-INVASIVE BLOOD FLOW ASSESSMENT: Computational Tool for Measuring Arterial Flow From CTEnrolling by invitationNCT07155616
- Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft PancreasRecruitingNCT07155525Not applicable
- CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)Not yet recruitingNCT07153289Phase 1/2
- Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.RecruitingNCT07148830Not applicable
- Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.RecruitingNCT07148128Phase 1/2
- Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsRecruitingNCT07145255Phase 1/2
- EUS- and US- Guided Biopsy for Pancreatic LesionNot yet recruitingNCT07138976
- A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic CancerNot yet recruitingNCT07138846Phase 3
- Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)RecruitingNCT07132541Phase 1
- MRI-guided Dose Intensification Program Locally Advanced Pancreatic CancerNot yet recruitingNCT07132060Not applicable
- HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic CancerRecruitingNCT07131514Phase 2
- A Study of PHN-012 in Patients With Advanced Solid TumorsRecruitingNCT07127874Phase 1
- Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic AdenocarcinomaRecruitingNCT07126158Phase 2
- A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic CancerRecruitingNCT07124611Not applicable
- DESTINY-PANTUMOUR04RecruitingNCT07124000
- Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic CancerRecruitingNCT07117045
- Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac PainRecruitingNCT07117032Phase 1
- FTT PET/CT in Pancreatic Neuroendocrine TumorsRecruitingNCT07114939Phase 1
- XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic CancerNot yet recruitingNCT07114666Not applicable
- A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic CancerRecruitingNCT07114315Phase 2
- Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic CancerNot yet recruitingNCT07108504Phase 2
- Pancreatic Cancer Diagnosis With FAPI-PET ImagingRecruitingNCT07098598Phase 2/3
- Feasibility and Effectiveness of Three-day Discharge After Distal PancreatectomyNot yet recruitingNCT07095621
- Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic CancerRecruitingNCT07091526
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsRecruitingNCT07090499Phase 1
- OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT07089940Early Phase 1
- Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary CancerRecruitingNCT07081360Phase 3
- A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic CancerRecruitingNCT07079228Phase 3
- Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderRecruitingNCT07072728Phase 2
- An International Study on Pediatric Patients With Rare Tumors.RecruitingNCT07072143
- Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic CancerRecruitingNCT07066995Phase 1/2
- A Study of MRG007 (ARR-217) in Patients With Advanced Solid TumorsRecruitingNCT07066657Phase 1
- A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)RecruitingNCT07066098Phase 3
- Spanish Registry of Direct Cholangiopancreatoscopy by Single OperatorNot yet recruitingNCT07064447
- Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
- Surveillance Discontinuation in 5 Year Stable Trivial Branch Duct Intraductal Papillary Mucinous NeoplasmsNot yet recruitingNCT07056972
- A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic CancerNot yet recruitingNCT07055568Not applicable
- CtDNA-guided Maintenance Therapy in Pancreatic CancerRecruitingNCT07054879
- A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic CancerRecruitingNCT07049055Phase 1/2
- MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic CancerRecruitingNCT07045571
- 24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDACRecruitingNCT07043270Phase 2
- Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis TechniquesRecruitingNCT07035587
- Construction and Clinical Application of the Immune Map of Pancreatic Cancer EvolutionRecruitingNCT07034339
- Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)RecruitingNCT07033689Early Phase 1
- Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory StudyRecruitingNCT07030348
- Study of CP-383 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT07030257Phase 1/2
- [Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck CancersNot yet recruitingNCT07026981Early Phase 1
- A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in ChinaNot yet recruitingNCT07026123
- Predictive Risk Factors for Pancreatic Fistula After PancreaticoduodenectomyRecruitingNCT07022015Not applicable
- A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsRecruitingNCT07020221Phase 1/2
- A Study of DCTY1102 Injection in Participants With Advanced Solid TumorsNot yet recruitingNCT07014878Phase 1
- Impact of GLP-1 Receptor Agonists on Patients With IPMNNot yet recruitingNCT07014709
- 22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid LesionsNot yet recruitingNCT07012694Not applicable
- Pancreas Screening in High Risk IndividualsNot yet recruitingNCT07012018
- Laparoscopic PancreaticoduodenectomyRecruitingNCT07009119Not applicable
- Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic CancerRecruitingNCT07006077Phase 2
- Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for CancerNot yet recruitingNCT06999512Phase 2/3